Literature DB >> 21269880

Utility of age-specific serum anti-Müllerian hormone concentrations.

David H Barad1, Andrea Weghofer, Norbert Gleicher.   

Abstract

This study assessed whether age-specific (as-) cutoffs for anti-Müllerian hormone (AMH) have higher specificity in reflecting ovarian reserve than non-age-specific (nas-) AMH values. as-AMH values were defined in 792 consecutive infertility patients by establishing as-quartiles of AMH within five age groups. Oocyte yields were then compared among women with AMH below or above the 25th centile at each age group. AMH continually decreased with advancing female age (P<0.0001) and differed significantly in each of five selected age categories (P<0.001). In 442 women who reached IVF, as-AMH was predictive of lower oocyte yield if below as-25th centile and of higher oocyte yield if above as-75th centile. Combined normal and elevated as-AMH demonstrated 6.4 times (95% CI 3.9-20.6) odds of retrieving more than four oocytes than low as-AMH. Like as-FSH, as-AMH better reflects ovarian reserve than nas-ovarian reserve testing. However, in contrast to as-FSH, as-AMH defines risk for diminished ovarian reserve or high oocyte yields (i.e. ovarian hyperstimulation syndrome) and, therefore, may be a particularly useful ovarian reserve test in younger women in whom diminished ovarian reserved is most frequently overlooked, and who are at highest risk for ovarian hyperstimulation syndrome.
Copyright © 2010 Reproductive Healthcare Ltd. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21269880     DOI: 10.1016/j.rbmo.2010.12.002

Source DB:  PubMed          Journal:  Reprod Biomed Online        ISSN: 1472-6483            Impact factor:   3.828


  27 in total

1.  More on the conversion of DHEA to testosterone.

Authors:  Aya Shohat-Tal; Aritro Sen; David H Barad; Vitaly A Kushnir; Norbert Gleicher
Journal:  Nat Rev Endocrinol       Date:  2015-07-14       Impact factor: 43.330

2.  How FSH and AMH reflect probabilities of oocyte numbers in poor prognosis patients with small oocyte yields.

Authors:  Norbert Gleicher; Sarah K Darmon; Vitaly A Kushnir; Andrea Weghofer; Qi Wang; Lin Zhang; David F Albertini; David H Barad
Journal:  Endocrine       Date:  2016-08-10       Impact factor: 3.633

Review 3.  A review of, and commentary on, the ongoing second clinical introduction of preimplantation genetic screening (PGS) to routine IVF practice.

Authors:  Norbert Gleicher; David H Barad
Journal:  J Assist Reprod Genet       Date:  2012-10-05       Impact factor: 3.412

4.  Defining ovarian reserve to better understand ovarian aging.

Authors:  Norbert Gleicher; Andrea Weghofer; David H Barad
Journal:  Reprod Biol Endocrinol       Date:  2011-02-07       Impact factor: 5.211

5.  Starting and resulting testosterone levels after androgen supplementation determine at all ages in vitro fertilization (IVF) pregnancy rates in women with diminished ovarian reserve (DOR).

Authors:  Norbert Gleicher; Ann Kim; Andrea Weghofer; Aya Shohat-Tal; Emanuela Lazzaroni; Ho-Joon Lee; David H Barad
Journal:  J Assist Reprod Genet       Date:  2012-12-05       Impact factor: 3.412

6.  Determining an anti-Mullerian hormone cutoff level to predict clinical pregnancy following in vitro fertilization in women with severely diminished ovarian reserve.

Authors:  Zaher Merhi; Athena Zapantis; Dara S Berger; Sangita K Jindal
Journal:  J Assist Reprod Genet       Date:  2013-08-21       Impact factor: 3.412

Review 7.  Reproductive ovarian testing and the alphabet soup of diagnoses: DOR, POI, POF, POR, and FOR.

Authors:  Lisa M Pastore; Mindy S Christianson; James Stelling; William G Kearns; James H Segars
Journal:  J Assist Reprod Genet       Date:  2017-10-02       Impact factor: 3.412

8.  Lessons from elective in vitro fertilization (IVF) in, principally, non-infertile women.

Authors:  Norbert Gleicher; Ann Kim; Andrea Weghofer; David H Barad
Journal:  Reprod Biol Endocrinol       Date:  2012-06-20       Impact factor: 5.211

9.  Differences in ovarian aging patterns between races are associated with ovarian genotypes and sub-genotypes of the FMR1 gene.

Authors:  Norbert Gleicher; Ann Kim; Andrea Weghofer; David H Barad
Journal:  Reprod Biol Endocrinol       Date:  2012-09-10       Impact factor: 5.211

10.  A pilot trial of large versus small diameter needles for oocyte retrieval.

Authors:  Vitaly A Kushnir; Ann Kim; Norbert Gleicher; David H Barad
Journal:  Reprod Biol Endocrinol       Date:  2013-03-20       Impact factor: 5.211

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.